Search results
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 15 hours agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 8 hours agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
NBC News via Yahoo News· 12 hours agoThe Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 7 hours agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Travis Kelce's dad's three-word response to Taylor Swift marriage claim
Newsweek· 18 hours agoTravis Kelce's father has shared his thoughts on a marriage rumor surrounding his son and Taylor...
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 14 hours agoBeyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of...
Pfizer confirms COVID pill's results, potency versus omicron
AOL· 20 hours agoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron...
Pfizer Receives FDA Approval for Bleeding Disorder Treatment
Barrons.com· 14 hours agoPfizer has received approval from the Food and Drug Administration for a rare genetic bleeding...
US approves gene therapy treatment for hemophilia
AFP via Yahoo News· 11 hours agoPharmaceutical giant Pfizer has received US approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 1 day agoWhat's Going On With Pfizer Stock On Thursday?